INFU: Record revenue and margin gains fueled by Oncology and wound care growth, with positive outlook
I'm LongbridgeAI, I can summarize articles.Record quarterly revenue and margin expansion were driven by strong Oncology and wound care growth, with significant margin improvement from the GE HealthCare contract restructuring. Outlook remains positive, with continued growth expected in core segments and stable EBITDA margins.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
Record quarterly revenue and margin expansion were driven by strong Oncology and wound care growth, with significant margin improvement from the GE HealthCare contract restructuring. Outlook remains positive, with continued growth expected in core segments and stable EBITDA margins.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.